{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:36:56Z","timestamp":1790847416410,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.clim.2015.04.018","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T01:06:22Z","timestamp":1430874382000},"page":"72-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches"],"prefix":"10.1016","volume":"159","author":[{"given":"Normi","family":"Bruck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clim.2015.04.018_bb0005","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00296-011-2249-4","article-title":"Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"32","author":"Hedrich","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.clim.2015.04.018_bb0010","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2015.04.018_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/095952879708000106","article-title":"On a form of chronic joint disease in children","volume":"80","author":"Still","year":"1897","journal-title":"Med.-Chir. Trans."},{"issue":"1-2","key":"10.1016\/j.clim.2015.04.018_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/pr.2013.187","article-title":"Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis","volume":"75","author":"Correll","year":"2014","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.clim.2015.04.018_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2012.07.022","article-title":"Systemic juvenile idiopathic arthritis","volume":"12","author":"Martini","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.clim.2015.04.018_bb0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2015.04.018_bb0035","first-page":"343","article-title":"Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR)","volume":"35","author":"Behrens","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2015.04.018_bb0040","first-page":"127","article-title":"The systemic autoinflammatory diseases: inborn errors of the innate immune system","volume":"305","author":"Brydges","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clim.2013.03.006","article-title":"Bridging the gap between autoinflammation and autoimmunity","volume":"147","author":"Hedrich","year":"2013","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2015.04.018_bb0050","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nri3261","article-title":"Lighting the fires within: the cell biology of autoinflammatory diseases","volume":"12","author":"Park","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0055","first-page":"1989","article-title":"Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort","volume":"29","author":"Oen","year":"2002","journal-title":"J. Rheumatol."},{"issue":"2 Pt 1","key":"10.1016\/j.clim.2015.04.018_bb0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-3476(05)80427-5","article-title":"Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis","volume":"120","author":"Schneider","year":"1992","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0065","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21774","article-title":"Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features","volume":"54","author":"Singh-Grewal","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0070","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.clim.2015.04.018_bb0075","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0080","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.22644","article-title":"Specific gene expression profiles in systemic juvenile idiopathic arthritis","volume":"56","author":"Ogilvie","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.clim.2015.04.018_bb0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.clim.2015.04.018_bb0090","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.38296","article-title":"Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study","volume":"66","author":"Vastert","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.clim.2015.04.018_bb0095","first-page":"2071","article-title":"Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis","volume":"31","author":"Verbsky","year":"2004","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0105","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"de Jager","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.coi.2011.07.005","article-title":"Cross-regulation between the IL-1beta\/IL-18 processing inflammasome and other inflammatory cytokines","volume":"23","author":"Barker","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0115","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00296-011-2019-3","article-title":"\u201cMutation negative\u201d familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies","volume":"32","author":"Hedrich","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/03009740801978889","article-title":"Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA\/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies","volume":"37","author":"Hedrich","year":"2008","journal-title":"Scand. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.clim.2015.04.018_bb0125","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.23604","article-title":"Autoinflammatory genes and susceptibility to psoriatic juvenile idiopathic arthritis","volume":"58","author":"Day","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.clim.2015.04.018_bb0130","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood.V87.11.4824.bloodjournal87114824","article-title":"Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis","volume":"87","author":"Cazzola","year":"1996","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0135","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis","volume":"34","author":"de Benedetti","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.clim.2015.04.018_bb0140","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti","year":"2001","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.clim.2015.04.018_bb0145","first-page":"1670","article-title":"Abnormal regulation of interleukin 6 in systemic juvenile idiopathic arthritis","volume":"28","author":"Pignatti","year":"2001","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0150","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.38984","article-title":"Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: results from a phase iii trial","volume":"67","author":"De Benedetti","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.molimm.2011.08.026","article-title":"Coactivation of TLR4 and TLR2\/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells","volume":"49","author":"Jin","year":"2011","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","article-title":"Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers","volume":"147","author":"Kessel","year":"2013","journal-title":"Clin. Immunol."},{"issue":"1-2","key":"10.1016\/j.clim.2015.04.018_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.02.023","article-title":"Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation","volume":"344","author":"Foell","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.clim.2015.04.018_bb0170","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/ard.2009.114363","article-title":"Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever","volume":"69","author":"Kallinich","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.clim.2015.04.018_bb0175","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowski","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2015.04.018_bb0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/humu.22169","article-title":"Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1beta","volume":"34","author":"Luksch","year":"2013","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.clim.2015.04.018_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/gene.2008.24","article-title":"Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis","volume":"9","author":"Stock","year":"2008","journal-title":"Genes Immun."},{"issue":"7","key":"10.1016\/j.clim.2015.04.018_bb0190","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.clim.2015.04.018_bb0195","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.11300","article-title":"The \u2212174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families","volume":"48","author":"Ogilvie","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2015.04.018_bb0200","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","article-title":"A novel 5\u2032-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis","volume":"44","author":"Donn","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0205","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/art.10882","article-title":"Functional and prognostic relevance of the \u2212173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis","volume":"48","author":"De Benedetti","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2015.04.018_bb0210","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B","article-title":"Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis","volume":"46","author":"Meazza","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"1-3","key":"10.1016\/j.clim.2015.04.018_bb0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12026-009-8150-5","article-title":"Cell type-specific regulation of IL-10 expression in inflammation and disease","volume":"47","author":"Hedrich","year":"2010","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.clim.2015.04.018_bb0220","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clim.2012.02.005","article-title":"Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury","volume":"143","author":"Hofmann","year":"2012","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clim.2011.08.012","article-title":"Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression","volume":"141","author":"Hofmann","year":"2011","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0230","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar2041","article-title":"Novel IL10 gene family associations with systemic juvenile idiopathic arthritis","volume":"8","author":"Fife","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0235","first-page":"912","article-title":"IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"28","author":"Moller","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"10.1016\/j.clim.2015.04.018_bb0240","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/rheumatology\/kep125","article-title":"Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by cluster analysis","volume":"48","author":"van den Ham","year":"2009","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0245","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/1744666X.2013.824670","article-title":"A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis\/chronic recurrent multifocal osteomyelitis and challenges facing the field","volume":"9","author":"Hedrich","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2015.04.018_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1546-0096-11-47","article-title":"Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO)","volume":"11","author":"Hedrich","year":"2013","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.clim.2015.04.018_bb0255","doi-asserted-by":"crossref","first-page":"310206","DOI":"10.1155\/2012\/310206","article-title":"Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO)","volume":"2012","author":"Hofmann","year":"2012","journal-title":"Int. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clim.2012.12.012","article-title":"Autoinflammatory bone disorders","volume":"147","author":"Morbach","year":"2013","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2015.04.018_bb0265","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2015.04.018_bb0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jobm.200900382","article-title":"Two laccase isoforms of the basidiomycete Cerrena unicolor VKMF-3196. Induction, isolation and properties","volume":"50","author":"Lisova","year":"2010","journal-title":"J. Basic Microbiol."},{"issue":"12","key":"10.1016\/j.clim.2015.04.018_bb0275","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00439-014-1502-9","article-title":"NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians","volume":"133","author":"Sales-Marques","year":"2014","journal-title":"Hum. Genet."},{"issue":"11","key":"10.1016\/j.clim.2015.04.018_bb0280","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jis588","article-title":"Crohn's disease susceptibility genes are associated with leprosy in the Vietnamese population","volume":"206","author":"Grant","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.clim.2015.04.018_bb0285","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","article-title":"Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection","volume":"106","author":"Hadchouel","year":"1985","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0290","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0295","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0300","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.23270","article-title":"Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Donn","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0305","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0310","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0315","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s10875-011-9583-x","article-title":"Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children","volume":"31","author":"Yanagimachi","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2015.04.018_bb0320","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3899\/jrheum.100655","article-title":"Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis","volume":"38","author":"Yanagimachi","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2015.04.018_bb0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12703\/P6-21","article-title":"Treatment advances in systemic juvenile idiopathic arthritis","volume":"6","author":"Beukelman","year":"2014","journal-title":"F1000Prime Rep."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0330","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jbspin.2006.12.004","article-title":"Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis","volume":"74","author":"Garcia-Carrasco","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0335","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jbspin.2010.09.002","article-title":"Current treatments for juvenile idiopathic arthritis","volume":"77","author":"Quartier","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0340","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-007-9120-0","article-title":"Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines","volume":"27","author":"Brinkman","year":"2007","journal-title":"J. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2015.04.018_bb0345","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0350","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3899\/jrheum.090952","article-title":"Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents","volume":"36","author":"Russo","year":"2009","journal-title":"J. Rheumatol."},{"issue":"25","key":"10.1016\/j.clim.2015.04.018_bb0355","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.clim.2015.04.018_bb0360","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0365","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"Boraschi","year":"2013","journal-title":"Semin. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0370","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.clim.2015.04.018_bb0375","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2015.04.018_bb0380","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.33342","article-title":"A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features","volume":"64","author":"Ruperto","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2015.04.018_bb0385","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.clim.2015.04.018_bb0390","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.clim.2015.04.018_bb0395","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.clim.2015.04.018_bb0400","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","article-title":"IL-1 Trap rilonacept in refractory adult onset Still's disease","volume":"71","author":"Petryna","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0405","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","article-title":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis","volume":"52","author":"Yokota","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.clim.2015.04.018_bb0410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1385\/CRIAI:28:3:231","article-title":"Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis","volume":"28","author":"Yokota","year":"2005","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"7","key":"10.1016\/j.clim.2015.04.018_bb0415","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"9","key":"10.1016\/j.clim.2015.04.018_bb0420","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/acr.22343","article-title":"Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: comment on the article by DeWitt et al.","volume":"66","author":"Kimura","year":"2014","journal-title":"Arthritis Care Res."},{"issue":"6","key":"10.1016\/j.clim.2015.04.018_bb0425","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","article-title":"Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?","volume":"66","author":"Nigrovic","year":"2014","journal-title":"Arthritis Rheumatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161500159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161500159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T20:45:10Z","timestamp":1717879510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161500159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S152166161500159X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.04.018","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}